Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Gabardi

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|June 4, 2017
CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled TrialsSamir G Mallat, Bassem Y Tanios, Houssam S Itani, et al.
Transplantation|February 3, 2015
Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant RecipientsSteven Gabardi, Natalya Asipenko, James Fleming, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2015
Assessing pharmacologic and nonpharmacologic risks in candidates for kidney transplantationAngela Q Maldonado, Eric M Tichy, Christin C Rogers, et al.
Pharmacotherapy|September 20, 2011
Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawalSpencer T Martin, Keri L Roberts, Sayeed K Malek, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 8, 2017
Early aspirin use and the development of cardiac allograft vasculopathyMiae Kim, Brian A Bergmark, Thomas A Zelniker, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2014
Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidatesMiae Kim, Keri R Townsend, Isabelle G Wood, et al.
Transplantation|May 24, 2014
Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatchLeonardo V Riella, Kassem Safa, Jude Yagan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2014
Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trialBelinda T Lee, Steven Gabardi, Monica Grafals, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 4, 2018
New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelinesSteven Gabardi, Martha Pavlakis, Chen Tan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 29, 2010
Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantationSteven Gabardi, Sushrut S Waikar, Spencer Martin, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Clinical Journal of the American Society of Nephrology : CJASN|June 4, 2017
CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled TrialsSamir G Mallat, Bassem Y Tanios, Houssam S Itani, et al.
Transplantation|February 3, 2015
Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant RecipientsSteven Gabardi, Natalya Asipenko, James Fleming, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2015
Assessing pharmacologic and nonpharmacologic risks in candidates for kidney transplantationAngela Q Maldonado, Eric M Tichy, Christin C Rogers, et al.
Pharmacotherapy|September 20, 2011
Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawalSpencer T Martin, Keri L Roberts, Sayeed K Malek, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 8, 2017
Early aspirin use and the development of cardiac allograft vasculopathyMiae Kim, Brian A Bergmark, Thomas A Zelniker, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2014
Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidatesMiae Kim, Keri R Townsend, Isabelle G Wood, et al.
Transplantation|May 24, 2014
Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatchLeonardo V Riella, Kassem Safa, Jude Yagan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2014
Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trialBelinda T Lee, Steven Gabardi, Monica Grafals, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 4, 2018
New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelinesSteven Gabardi, Martha Pavlakis, Chen Tan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 29, 2010
Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantationSteven Gabardi, Sushrut S Waikar, Spencer Martin, et al.
Pageof 7